GKB Ophthalmics Board of Directors

Get the latest insights into the leadership at GKB Ophthalmics. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
KG GuptaChairman & Managing Director
Vikram GuptaPromoter & Non-Executive Director
Pooja BicholkarCompany Secretary & Compliance Officer
Purushottam S MantriNon Executive Independent Director
Sandhya Ajit KamatNon Executive Independent Director
Ninad Gurudas KamatNon Executive Independent Director
Cedric LoboWhole Time Director

GKB Ophthalmics Share price

GKB

71.89

1.69 (2.41%)
Last updated on 23 Apr, 2026 | 13:01 IST
Today's High

72.70

Today's Low

71.89

52 Week Low

45.25

52 Week High

91.70

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

GKB Ophthalmics FAQs

The board at GKB Ophthalmics consists of experienced professionals, including KG Gupta, Vikram Gupta, and others, overseeing the company’s strategic and corporate governance.

Directors at GKB Ophthalmics are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, KG Gupta is the current chairman at GKB Ophthalmics.

Executive directors at GKB Ophthalmics are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, GKB Ophthalmics adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At GKB Ophthalmics, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost